MedTrace Logo

Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment

NCT01203397 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2021-02-24

No results posted yet for this study

Summary

Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate in the treatment of superficial varicose veins

Conditions

  • VARICOSE VEINS

Interventions

DRUG

TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G

APLIED 4 TIMES/DAY AT LESION

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • FLAVIA ADDOR · Medcin Instituto da Pele

  • Felipe Pinho, MD · EMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01203397 on ClinicalTrials.gov